Drug Name Identification an Ignored Patient's Problem That Needs a Solution

Each of the recruited patient was given 3 different placebo drugs with 3 different mad up names to be taken for one month with different regiments.

The drug name resembled a real drug but with enough difference to prevent the patient from trying to buy it as a safety precaution. The name was printed on the box in English and Arabic letters. The coloured shape was printed to 2x2 cm dimension.

After one month the participants were intervened by a doctor blinded to the study. The doctor asked about the drug history of the patient. If the participant could remember the drug name and its correct regiment the doctor documented that. if the patent failed to remember the correct name and its regiment then the doctor asked the patient to try and remember anything about the drug.

Then the patient would be asked about the symbol on the drug and was it helpful for him in any way.

Study Overview

• Status: Recruiting
• Conditions: Remember the Name of a Given Drug
• Intervention / Treatment: Drug: Placebo

Detailed Description

A scoring system was used to evaluate pateints memory of the drugs used 0- 3 0 is the minimal score and will be given if no recall of any drug name and 3 is the maximum score and will be given if the patient could remember the name of the tree drugs correctly.

The same scoring system was used for the symbols

• Study Type: Interventional
• Enrollment (Anticipated): 500
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: nouran t abdelsalam; Phone Number: +201060122230; Email: yasser.osman@alexmed.edu.eg

Study Locations

• Egypt
  • Alexandria, Egypt, 0203
    • Recruiting
    • Alexandria University
    • Principal Investigator: Yasser m osman, assist prof

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 16 years to 76 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• ASA I and II patients

Exclusion Criteria:

• severe or life-threatening condition
• severe visual impairment
• mental or cognitive dysfunction

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Screening
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: patients receiving the placebo medication; tree different placebo drugs with tree different names and symbols one will be given twice daily one once in the morning one once before bedtime	Drug: Placebo; tree different placebo drugs with tree different names and scheduled will be given; Other Names: placebo drugs

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
score for remembering the drug name	A scoring system was used to evaluate patients memory of the drugs name used 0- 3 0 is the minimal score and will be given if no recall of any drug name and 3 is the maximum score and will be given if the patient could remember the name of the tree drugs correctly.	memory will be tested after one month from prescribing the drugs
score for remembering the drug symbol	A scoring system was used to evaluate patients memory of the drugs symbol used 0- 3 0 is the minimal score and will be given if no recall of any drug symbol and 3 is the maximum score and will be given if the patient could remember the symbol of the tree drugs correctly.	memory will be tested after one month from prescribing the drugs

Collaborators and Investigators

• Sponsor: Alexandria University
• Investigators: Principal Investigator: yasser M osman, Alexandria University

Study record dates

Study Major Dates

• Study Start (Actual): April 1, 2022
• Primary Completion (Anticipated): June 1, 2022
• Study Completion (Anticipated): June 1, 2022

Study Registration Dates

• First Submitted: April 17, 2022
• First Submitted That Met QC Criteria: April 22, 2022
• First Posted (Actual): April 25, 2022

Study Record Updates

• Last Update Posted (Actual): April 25, 2022
• Last Update Submitted That Met QC Criteria: April 22, 2022
• Last Verified: April 1, 2022

More Information

Terms related to this study

• Other Study ID Numbers: 0305534

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: No

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No